Provided by Tiger Trade Technology Pte. Ltd.

Mesoblast

14.08
-0.2400-1.68%
Post-market: 14.080.00000.00%19:30 EDT
Volume:265.21K
Turnover:3.74M
Market Cap:1.83B
PE:-31.71
High:14.34
Open:14.34
Low:14.01
Close:14.32
52wk High:21.50
52wk Low:13.05
Shares:129.69M
Float Shares:86.19M
Volume Ratio:1.25
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4440
EPS(LYR):-0.4441
ROE:-9.86%
ROA:-4.11%
PB:3.21
PE(LYR):-31.71

Loading ...

Mesoblast reported Q4 Ryoncil net revenue of $36M

TIPRANKS
·
Jul 13

Mesoblast rises 6.2%

TIPRANKS
·
Jul 13

Mesoblast Reports $36 Million Ryoncil Revenue for Fiscal Q4

MT Newswires Live
·
Jul 10

Mesoblast's Fiscal Fourth Quarter Net Revenue from MSC Therapy Product Sales Beats Jefferies Forecast

MT Newswires Live
·
Jul 10

Mesoblast Says Ryoncil Net Revenue Exceeds Expectations; Shares Up 5%

MT Newswires Live
·
Jul 10

Press Release: Ryoncil(r) Delivers Net Revenue of Us$36m for the Fourth Quarter Ended 30 June 2026

Dow Jones
·
Jul 10

Mesoblast posts US$115m first-year Ryoncil revenue and strengthens capital position

TIPRANKS
·
Jul 10

Mesoblast Ltd - Ryoncil Q4 Net Revenue of Us$36m and Us$115m for Full Year

THOMSON REUTERS
·
Jul 10

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Mesoblast Limited (OtherMEOBF) and Cogstate Ltd (OtherCOGZF)

TIPRANKS
·
Jul 02

Mesoblast Receives Biologics License Application Filing Number From US FDA; Shares Up 3%

MT Newswires Live
·
Jul 01

Mesoblast receives BLA filing number from FDA for rexlemestrocel-L review

TIPRANKS
·
Jul 01

Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs

GlobeNewswire
·
Jul 01

Mesoblast - Requests Modular Review of Bla for Rexlemestrocel-l in End-stage Heart Failure with Lvad

THOMSON REUTERS
·
Jul 01

Mesoblast - Rexlemestrocel-l Receives Orphan Drug and Rmat Designations

THOMSON REUTERS
·
Jul 01

JPMorgan exits substantial holder position in Mesoblast

TIPRANKS
·
Jun 29

Mesoblast Accesses $50 Million Credit Line to Refinance Debt Obligations

MT Newswires Live
·
Jun 25

Mesoblast Draws $50 Million From Facility Provided by Shareholder

MT Newswires Live
·
Jun 25

Press Release: Mesoblast Draws US$50 Million from Five-year Non-dilutive Facility

Dow Jones
·
Jun 25

Mesoblast Taps US$50m Low-Cost Facility to Retire High-Cost Debt and Fund Growth

TIPRANKS
·
Jun 25

Mesoblast Says JPMorgan Ceases to be Substantial Holder

MT Newswires Live
·
Jun 12